- Investing Ideas
- Danish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Danish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
H. Lundbeck
Market Cap: DKK 39.0b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 40.46
7D
-3.9%
1Y
16.3%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 307.60
7D
-8.3%
1Y
0.6%
ChemoMetec
Market Cap: DKK 7.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 418.00
7D
1.2%
1Y
-17.7%
Genmab
Market Cap: DKK 113.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,878.00
7D
-1.6%
1Y
31.2%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 178.70
7D
0.2%
1Y
-25.2%
ALK-Abelló
Market Cap: DKK 47.6b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 217.00
7D
-4.1%
1Y
15.9%
Zealand Pharma
Market Cap: DKK 21.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 316.60
7D
3.5%
1Y
-1.8%